Allscripts Continues to Lead in Interoperability, Driving Successful Healthcare Delivery

AllscriptsAllscripts (NASDAQ: MDRX) remains committed to effective interoperability in healthcare delivery. A leader in interoperability and open platforms, the company has made it a priority to deliver clinicians accessible, clinically relevant information at the point of care, creating a community patient record and enabling successful care delivery.

Allscripts dbMotion™ Solution has been delivering clinically relevant, meaningful interoperability for many years. With dbMotion, which enables the sharing of data across different EHR systems regardless of vendor, clinicians can engage their care teams and improve access to real-time, harmonized information from across the care continuum. Used around the world in the United States, Australia, Canada, United Kingdom and Israel, the solution leverages and shares data assets, achieving safer high-quality clinical outcomes.

Every month the following volumes are enabled:

  • 14M+ unique patient transactions are received in dbMotion
  • 31,000+ providers and 128,000+ users interact with dbMotion
  • 2,700+ ambulatory and post-acute facilities transmit data with dbMotion
  • 1,000+ hospitals transmit data with dbMotion

Over the past 12 months, dbMotion has achieved significant client success with the sharing of information including:

  • 1B+ pieces of patient demographics data
  • 650M+ observation results
  • 350M+ pharmacy data
  • 289M+ documents
  • 104M+ orders (pharmacy/treatment)
  • 58M+ full patient data records

Allscripts was recently recognized as a growth and innovation top-performing leader in Frost & Sullivan’s Frost Radar™: US Healthcare Data Interoperability Market, 2020. The report states that Allscripts demonstrates superior interoperability across the entire HIT ecosystem by enabling the direct integration of third-party clinical decision support applications into the company’s platforms through on-premise or cloud deployment models.

"Allscripts has advocated for having an open platform since 2007 and we believe interoperability is the foundation for advancing healthcare - data and access should be Open. For Everyone™," said Allscripts Chief Executive Officer, Paul M. Black. "Our systems - all of them - should be able to talk to each other. Through dbMotion, we have helped providers all around the world collaborate, deliver higher-quality care, lower costs and help consumers achieve better outcomes. We are proud of the interoperability tools we offer, creating a health ecosystem where critical data is made useful by combining isolated islands of community information into a single, actionable patient record. We remain committed to assisting in successful healthcare delivery for today and tomorrow."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...